US$ 26.56
parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Genome editing in Parkinson's disease:
Description
E-mail: [email protected] Received: November 05, 2025 Accepted: December 17, 2025 Published: December 22, 2025 Abstract Redoxins, oxidoreductases of the thioredoxin (Trx) family, are important regulators of signaling processes

Se metabolism is known to be affected by sex (Schomburg, 2016

Aksu EH, Kandemir FM, Kkler S

Each of these directions remains at the level of preclinical research and requires independent verification
